Clinical Trial Update: Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update for TRC150094 evaluating safety and efficacy to reduce cardiovascular risk in adults with diabetes, dyslipidemia, and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Dyslipidemias
• Hypertension

Drugs mentioned

• TRC150094

Snippet

Sponsor: Torrent Pharmaceuticals Limited | Conditions: Diabetes, Dyslipidemias | Phase 3 | Status: UNKNOWN